TY - JOUR
T1 - Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis
AU - Dittrich, A. Susanne
AU - Kühbandner, Iris
AU - Gehrig, Stefanie
AU - Rickert-Zacharias, Verena
AU - Twigg, Matthew
AU - Wege, Sabine
AU - Taggart, Clifford C.
AU - Herth, Felix
AU - Schultz, Carsten
AU - Mall, Marcus A.
N1 - Funding Information:
Conflict of interest: A.S. Dittrich reports grants from the German Cystic Fibrosis Association Mukoviszidose e.V. (number 1605) and the Heidelberg Research Centre for Molecular Medicine Career Development Fellowship, during the conduct of the study. F. Herth has received grants, personal fees and non-financial support from Novartis, Chiesi, Boehringer, Astra, Uptake, Broncus, Pulmonx, Olympus, BTG and Ethicon, outside the submitted work. C. Schultz co-founded SiChem in 2001 and still own part of the company. SiChem is the sole producer of FRET probes used in this manuscript. M.A. Mall received grants from the German Federal Ministry of Education and Research (grant contract number 82DZL00401 and 82DZL004A1) and the European Commission (Seventh Framework Programme Project number 603038 CFMatters), during the conduct of the study; and personal fees for advisory board participation, consultancy, and lecture fees from Vertex, personal fees for advisory board participation and consultancy, from Spyrex, Polyphor and Boehringer Ingelheim, personal fees for advisory board participation from ProQR, PTC Pharmaceuticals, Arrowhead and Pro Axis, and lecture fees from Bayer, outside the submitted work. In addition, M.A. Mall has a patent on the Scnn1b-transgenic mouse with royalties paid, and a patent on use of sodium channel blockers for early therapy of obstructive lung diseases issued.
Funding Information:
Support statement: Funded in part by the German Ministry for Education and Research (FKZ 82DZL00401 and FKZ 82DZL004A1 to M.A. Mall and C. Schultz), the European Commission (Seventh Framework Programme Project No. 603038 CFMatters to M.A. Mall) and the German Cystic Fibrosis Association Mukoviszidose e.V. (Project number 1605 to A.S. Dittrich). A.S. Dittrich was supported by a HRCMM (Heidelberg Research Centre for Molecular Medicine) career development fellowship. Funding information for this article has been deposited with the Crossref Funder Registry.
Publisher Copyright:
© ERS 2018.
PY - 2018
Y1 - 2018
N2 - Neutrophil elastase (NE) is a key risk factor for severity of cystic fibrosis (CF) lung disease. Recent studies identified increased NE activity on the surface of airway neutrophils from CF-like mice and patients with CF. However, the role of surface-bound NE in CF lung disease remains unknown. We determined the relationship between surface-bound NE activity and severity of lung disease in CF. Surface-bound NE activity was measured on sputum neutrophils from 35 CF patients and eight healthy controls using novel lipidated Förster resonance energy transfer reporters and correlated with free NE activity, neutrophil counts, interleukin-8, myeloperoxidase and antiproteases in sputum supernatant, and with lung function parameters. Surface-bound NE activity was increased in CF compared to healthy controls (p<0.01) and correlated with free NE activity (p<0.05) and other inflammation markers (p<0.001). Surface-bound and free NE activity correlated with forced expiratory volume in 1 s % predicted (p<0.01 and p<0.05), but only surfacebound NE activity correlated with plethysmographic functional residual capacity % pred (p<0.01) in patients with CF. We demonstrate that surface-bound NE activity on airway neutrophils correlates with severity of lung disease in patients with CF. Our results suggest that surface-bound NE activity may play an important role in the pathogenesis and serve as novel biomarker in CF lung disease.
AB - Neutrophil elastase (NE) is a key risk factor for severity of cystic fibrosis (CF) lung disease. Recent studies identified increased NE activity on the surface of airway neutrophils from CF-like mice and patients with CF. However, the role of surface-bound NE in CF lung disease remains unknown. We determined the relationship between surface-bound NE activity and severity of lung disease in CF. Surface-bound NE activity was measured on sputum neutrophils from 35 CF patients and eight healthy controls using novel lipidated Förster resonance energy transfer reporters and correlated with free NE activity, neutrophil counts, interleukin-8, myeloperoxidase and antiproteases in sputum supernatant, and with lung function parameters. Surface-bound NE activity was increased in CF compared to healthy controls (p<0.01) and correlated with free NE activity (p<0.05) and other inflammation markers (p<0.001). Surface-bound and free NE activity correlated with forced expiratory volume in 1 s % predicted (p<0.01 and p<0.05), but only surfacebound NE activity correlated with plethysmographic functional residual capacity % pred (p<0.01) in patients with CF. We demonstrate that surface-bound NE activity on airway neutrophils correlates with severity of lung disease in patients with CF. Our results suggest that surface-bound NE activity may play an important role in the pathogenesis and serve as novel biomarker in CF lung disease.
UR - http://www.scopus.com/inward/record.url?scp=85054378460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054378460&partnerID=8YFLogxK
U2 - 10.1183/13993003.01910-2017
DO - 10.1183/13993003.01910-2017
M3 - Article
C2 - 29545279
AN - SCOPUS:85054378460
SN - 0903-1936
VL - 51
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 3
M1 - 1701910
ER -